StockData
Innate Pharma SA logo

Innate Pharma SA (IPHA) stock

IPHANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as IPHYF
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 0/30
$1.03−0.30 (-22.56%)

Close on Nov 18, 2026Market cap $96.53MP/E –Yield –

Innate Pharma gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Innate Pharma

Innate Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Innate Pharma figures

See a number that looks wrong?